Deal facts
- Buyer
- Medpal AI plc
- Target
- Universal Pharmacy Ltd
- Deal value
- GBP 45,000
- Announced
- 16 February 2026
- Status
- Completed
- Sector
- Healthcare
- Country
- United Kingdom
- Consideration
- cash
Sources
Medpal AI plc has agreed to acquire Universal Pharmacy Ltd in a strategic acquisition valued at £45,000. The transaction was settled entirely in cash and relates to the pharmacy and healthcare services sector. Although the deal was announced on 16 February 2026, the completion date is recorded as 13 February 2026. The target company operates within the United Kingdom, and the buyer is a public limited company focused on artificial intelligence solutions for the industry.
The acquisition represents a significant expansion for the buyer into physical retail healthcare services. Both parties have confirmed that the transaction has been completed as of the stated date. The deal structure involves a straightforward purchase of the target business without any complex earn-out provisions or debt assumptions reported in the available data. The transaction is now final and the target operates as a subsidiary of the acquiring entity.
More M&A Tools
Explore the Toolkit
Tools, frameworks and AI assistants designed for entrepreneurs serious about M&A.
Access nowDeal timeline
1 update- CompletedClosed
Medpal AI plc to acquire Universal Pharmacy Ltd
{ "headline": "Completion of Acquisition", "issuer": "Medpal AI PLC (MPAL)", "announcement_date": "2026-02-16T07:00:00", "category_code": "Completion of Acquisition", "body": "Disclaimer* \n\n 16 February 2026 \n\n Medal AI plc \n\n (\"MedPal AI\" or the \"Company\") \n\n Completion of Acquisition of Universal Pharmacy assets and Expansion of Robotic Distribution Facility in Swaffham \n\
LSE RNS
Explore
Browse adjacent archives
Jump from this deal into the sector, buyer, deal type, and year views that carry the strongest contextual signal.
Similar deals
Similar deals
Other Healthcare M&A activity tracked by Exit Mode.
Circle Health Holdings Limited to acquire CHC Healthcare Holdings Limited
Circle Health Holdings Limited has agreed to acquire CHC Healthcare Holdings Limited in a strategic acquisition within the healthcare sector. Both entities are based in…
- Buyer
- Circle Health Holdings Limited
- Target
- CHC Healthcare Holdings Limited
- Deal value
- Not disclosed
- Deal type
- strategic acquisition
GSK plc to acquire Nuvalent, Inc
GSK plc has agreed to acquire Nuvalent, Inc in a strategic acquisition valued at $10.6 billion. The transaction, announced and completed on 15 July 2026, involves full c…
- Buyer
- GSK plc
- Target
- Nuvalent, Inc
- Deal value
- USD 10,600,000,000
- Deal type
- strategic acquisition
Volex plc to acquire Kepler SignalTek Ltd
Volex plc has agreed to acquire Kepler SignalTek Ltd, a healthcare sector business based in the United Kingdom. The strategic acquisition was announced and completed on…
- Buyer
- Volex plc
- Target
- Kepler SignalTek Ltd
- Deal value
- USD 89,400,000
- Deal type
- strategic acquisition
Lixte Biotechnology Holdings, Inc. to acquire Nomad Transportable Power Systems, Inc.
Lixte Biotechnology Holdings, Inc. has agreed to acquire Nomad Transportable Power Systems, Inc. in a strategic acquisition within the Healthcare sector. The transaction…
- Buyer
- Lixte Biotechnology Holdings, Inc.
- Target
- Nomad Transportable Power Systems, Inc.
- Deal value
- Not disclosed
- Deal type
- strategic acquisition
Public Company Management Corporation to acquire Physicians Capital Management Corporation
Public Company Management Corporation has agreed to acquire Physicians Capital Management Corporation in a strategic acquisition within the healthcare sector. The transa…
- Buyer
- Public Company Management Corporation
- Target
- Physicians Capital Management Corporation
- Deal value
- Not disclosed
- Deal type
- strategic acquisition
Buyer history
Medpal AI plc
See every published Exit Mode archive entry where this buyer appears.
View buyer profileMethodology
How this page is built
Layer 1 facts come from source documents, Layer 2 turns those facts into a readable narrative, and Layer 3 only appears where the editorial team flags a founder-relevant deal.
Back to the archive
